DXCM Stock Analysis: Buy, Sell, or Hold?
DXCM - DexCom, Inc.
$76.65
-1.33 (-1.71%)
▼
5d:
+2.25%
30d:
+4.77%
90d:
+25.18%
BUY
MODERATE Confidence
Analysis Updated: Jul 17, 2026 12:00 AM ET
Earnings: Jul 29, 2026
10d
Smart Money Distribution
None View Scanner →
Strength: 6.7/10
Get Alerted When DXCM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: DXCM shows positive signals but monitor for confirmation. Market pricing in 1.1% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: DXCM shows positive signals but monitor for confirmation. Market pricing in 1.1% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$126.82
Based on 11.5% avg growth
INTRINSIC VALUE TODAY
$78.74
2.7% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 24.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: DXCM is currently trading at $76.65, which is considered extended relative to its 30-day fair value range of $69.93 to $75.86. The stock's valuation (Forward PE: 24.9) is in line with its historical norms (24.1). At these levels, the market is pricing in 1.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, DXCM is in a downtrend. Immediate support is located at $69.74, while resistance sits at $79.15.
Market Sentiment: DXCM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $85.46 (+11.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, DXCM is in a downtrend. Immediate support is located at $69.74, while resistance sits at $79.15.
Market Sentiment: DXCM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $85.46 (+11.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$69.93 -
$75.86
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
60.5%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($85.46)
- NEUTRAL: Market pricing in 1.1% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$69.93 -
$75.86
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$69.74
Resistance Level
$79.15
Current Trend
Downtrend
Technical data as of
Jul 17, 2026
Fundamental Context
Forward P/E (Next Year Est.)
24.91
Wall Street Target
$85.46
(+11.5%)
Revenue Growth (YoY)
15.0%
Earnings Growth (YoY)
92.2%
Profit Margin
19.3%
Valuation Premium vs History
+1.1% premium
PE vs Historical
24.9 vs 24.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.1%
(market-implied from PE analysis)
1-Year Target
$77.49
(+1%)
2-Year Target
$78.35
(+2%)
3-Year Target
$79.21
(+3%)
3-Yr Target (if PE normalizes)
(PE: 25→24)
PE COMPRESSION
$76.64
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 24.9, Growth: 18.9%)
$128.74
(+68%)
Base:
(SPY PE: 21.0, Growth: 18.9%)
$108.60
(+42%)
Bear:
(PE: 17.9, Growth: 18.9%)
$92.31
(+20%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (33x PE), but valuation improves significantly next year (25x PE) as earnings recover.
Trailing PE: 33.47 | Current EPS (TTM): $2.33
Bull Case
$113.30
(+48%)
Analyst growth 32.1%, PE expands to 36.8
Base Case
$103.00
(+34%)
Market implied 32.1%, PE stable at 33.5
Bear Case
$53.03
(-31%)
Severe decline -20.0%, PE contracts to 28.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 18, 2026 3:34 AM ET
Data refreshes hourly during market hours. Next update: 4:34 AM
Data refreshes hourly during market hours. Next update: 4:34 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DXCM showing a specific setup today?
Insider Activity (6 Months)
3
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Michael Jon Brown
SELL
1700 shares
2026-04-15
Ro Khanna
SELL
2026-03-30
Ro Khanna
SELL
2026-03-23
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$74 | 62 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$116 | 67 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$97 | 66 BUY |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$79 | 56 HOLD |
|
PEN
Penumbra Inc |
STRONG BUY
18 analysts |
$363 | 64 BUY |
Advanced DXCM Option Strategies
Professional options setups generated by AI based on today's DXCM price and gamma walls.
